C4 Therapeutics Inc (CCCC:NASDAQ)

$2.77 0.38 (15.90%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 80

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly

Analysed C4 Therapeutics Inc (CCCC:NASDAQ) News Sources

Strong Analyst Confidence in C4 Therapeutics (CCCC)’s Cemsidomide Drives 270% Upside Potential

Yahoo Finance

external link

C4 Therapeutics Announces First Patient Dosed in Phase 2 MOMENTUM Trial of Cemsidomide, an Oral IKZF1/3 Degrader, in Combination with Dexamethasone for Relapsed/Refractory ...

Yahoo Finance

external link

Fate Therapeutics, Inc. (FATE)

Yahoo Finance

external link
CCCC stock
CCCC stock price
CCCC stock price today
CCCC stock prediction
CCCC earnings date
CCCC news
CCCC price
CCCC share
CCCC share price
CCCC shares
CCCC ceo
CCCC premarket
$CCCC
CCCC ticker
CCCC after hours
CCCC stock
CCCC stock price
CCCC stock price today
CCCC stock prediction
CCCC earnings date
CCCC news
CCCC price
CCCC share
CCCC share price
CCCC shares
CCCC ceo
CCCC premarket
$CCCC
CCCC ticker
CCCC after hours

C4 Therapeutics Inc (CCCC:NASDAQ) FAQs

toggle

What is the current price of C4 Therapeutics Inc (CCCC:NASDAQ)?

The current price of C4 Therapeutics Inc (CCCC:NASDAQ) is $2.77.


toggle

C4 Therapeutics Inc (CCCC:NASDAQ) absolute price change since previous trading day?

The absolute price change of C4 Therapeutics Inc (CCCC:NASDAQ) since the previous trading day is $0.38.


toggle

C4 Therapeutics Inc (CCCC:NASDAQ) percentage price change since previous trading day?

The percentage price change of C4 Therapeutics Inc (CCCC:NASDAQ) since the previous trading day is 15.90%.


toggle

What is This Week's average sentiment score for C4 Therapeutics Inc (CCCC:NASDAQ)?

This Week's average sentiment score for C4 Therapeutics Inc (CCCC:NASDAQ) is 80 out of 100.


toggle

What is This Week's average sentiment for C4 Therapeutics Inc (CCCC:NASDAQ)?

This Week's sentiment for C4 Therapeutics Inc (CCCC:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.